Cipla & Pharma Stocks Surge on US Drug Price News

  Published 1 year ago

Cipla shares are rising, mirroring gains in the pharma sector, fueled by reports the US has exempted generic drugs from planned price cuts. This news from Reuters is boosting investor confidence.

  • Cipla stock is trading higher today.
  • US exempts generics from price cuts.
  • Positive outlook for pharma companies.

You might like these

IndiGo Expands Internationally, Challenges Air India

Bharti Airtel Rises on Strong Growth, CLSA Analysis

June Heatwave Cuts India’s Tea Output

Emcure Pharma Gains on JM Buy Call

TCS & CEB: AI-Powered Reconciliation for Social Development

HIL Wins 365‑Day Toll Plaza Contract

EV Sales Surge in India: 7.7% Market Share

News that matters the most ⚡